Active ingredientEtodolacCat. No. P-E133-001CAS 41340-25-4Family · Pharmaceutical analytical standards
Etodolac
A non-steroidal anti-inflammatory drug that acts preferentially on COX-2, patented in 1971, in clinical use since 1985 and approved in the United States in 1991: it is used for pain and inflammation in osteoarthritis and rheumatoid arthritis. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?The medicine is a mixture of two mirror-image forms: the R form does not act on cyclooxygenases, but in liver cancer cells it lowers levels of beta-catenin, a cell growth protein.
Go to the active ingredient →Active ingredientEtodolacCat. No. P-E133-001CAS 41340-25-4
Pharmacopoeial impurityEtodolac EP Impurity ACat. No. P-E133-002CAS 41339-67-7
Pharmacopoeial impurityEtodolac EP Impurity BCat. No. P-E133-003CAS 41340-19-6
Pharmacopoeial impurityEtodolac EP Impurity CCat. No. P-E133-004CAS 109518-47-0
Pharmacopoeial impurityEtodolac EP Impurity DCat. No. P-E133-005CAS 57917-63-2
Pharmacopoeial impurityEtodolac EP Impurity ECat. No. P-E133-006CAS 57817-27-3
Pharmacopoeial impurityEtodolac EP Impurity FCat. No. P-E133-007CAS 849630-65-5
Pharmacopoeial impurityEtodolac EP Impurity GCat. No. P-E133-008CAS 57816-83-8
Pharmacopoeial impurityEtodolac EP Impurity HCat. No. P-E133-009CAS 41340-36-7
Pharmacopoeial impurityEtodolac EP Impurity ICat. No. P-E133-010
Pharmacopoeial impurityEtodolac EP Impurity JCat. No. P-E133-011CAS 115066-03-0
Pharmacopoeial impurityEtodolac EP Impurity KCat. No. P-E133-012CAS 122188-02-7
Pharmacopoeial impurityEtodolac EP Impurity LCat. No. P-E133-013CAS 2789629-50-9
MetaboliteEtodolac Acyl GlucuronideCat. No. P-E133-014CAS 79541-43-8
Isotopically labelled(R)-Etodolac-d3Cat. No. P-E133-015
Isotopically labelled(S)-Etodolac-d3Cat. No. P-E133-016
Isotopically labelledrac-Etodolac-13C-d3Cat. No. P-E133-017
NitrosamineN-Nitroso Etodolac Impurity 1Cat. No. P-E133-018
NitrosamineN-Nitroso EtodolacCat. No. P-E133-019
NitrosamineN-Nitroso Etodolac EP Impurity HCat. No. P-E133-020
NitrosamineN-Nitroso Etodolac Impurity 2Cat. No. P-E133-021
Impurity(+)-Desethyl Methyl EtodolacCat. No. P-E133-022CAS 109518-49-2
Impurity(R)-EtodolacCat. No. P-E133-023CAS 87226-41-3
Impurity(S)-EtodolacCat. No. P-E133-024CAS 87249-11-4
Impurity(E)-3-(7-Ethyl-3-(2-hydroxyethyl)-1H-indol-2-yl)pent-2-enoic AcidCat. No. P-E133-025CAS 2508023-02-5
Impurity5-Hydroxy EtodolacCat. No. P-E133-026CAS 314734-19-5
Impurity6-Hydroxy EtodolacCat. No. P-E133-027CAS 101901-06-8
Impurity7-Hydroxy EtodolacCat. No. P-E133-028CAS 101901-07-9
Impurity7-isopropyl TryptopholCat. No. P-E133-029CAS 57817-12-6
Impurity7-PropyltryptopholCat. No. P-E133-030CAS 57817-15-9
Impurity8-(1-Hydroxyethyl) EtodolacCat. No. P-E133-031CAS 101901-08-0
ImpurityEtodolac Ethyl EsterCat. No. P-E133-034CAS 200880-23-5
ImpurityEtodolac Impurity 1Cat. No. P-E133-035
ImpurityEtodolac Impurity 2Cat. No. P-E133-037
ImpurityEtodolac Impurity 3Cat. No. P-E133-038
ImpurityEtodolac Impurity 4Cat. No. P-E133-039
ImpurityEtodolac Impurity 5Cat. No. P-E133-040
ImpurityN-Methyl EtodolacCat. No. P-E133-041CAS 849630-94-0No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceEtodolac CRSEDQM code E2470000Family EtodolacImpurityEtodolac impurity H CRSEDQM code E2470050Family EtodolacImpurityEtodolac impurity mixture CRSEDQM code Y0002335Family EtodolacNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.